6Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
7Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
8Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
9Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
10Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
6Balion C, Santaguida PL, Hill S,et al. Testing for BNP and NT- proBNP in the diagnosis and prognosis of heart failure[J]. Evid Rep Technol Assess(Full Rep) ,2006, (142) : 1-147.
7Chandrashekhar Y. Role of apoptosis in ventricular remodeling [J]. Curt Heart Fail Rep,2005,2(1 ):18-22.
8Ledoux J, Gee DM, Leblanc N. Increased peripheral resistance in heart failure: NEW evidence suggests an alteration in caseular smooth muscle function[J]. Br J Pharmacol, 2003,139 (7) : 1245-1248.
